Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Jose Cuervo: Salida a bolsa
Jansat Mayench, Oriol; Carbonell López; Óscar; Rahnema Alavi, AhmadCaso F-975FinanzasLa salida a bolsa de Jose Cuervo (JC) en febrero de 2017 marcó todo un hito en el mundo del tequila por el hecho de ser la primera empresa tequilera del mundo en salir a bolsa. La salida de la empresa mexicana fue especialmente relevante porque se produjo meses después de la llegada a la Casa Blanca del presidente Donald Trump, que había criticado al Gobierno mexicano y había planteado la necesidad de renegociar el Tratado de Libre Comercio de Am...Desde 8,20 €
-
Note on Biotech Business Development
Hamermesh, Richard G.; Higgins, Robert F.Caso HBS-807032-EIniciativa emprendedoraTo maximize their effectiveness, color cases should be printed in color. Describes the business development process in biotechnology companies. Topics covered include: participants in the licensing process and their interests, the major steps in the licensing process, the terms that are part of most agreements, and the most contentious issues that arise in the implementation of licensing agreements. Includes color exhibits.Desde 8,20 €
-
Cynthia Fisher and the Rearing of ViaCell, Teaching Note
Hamermesh, Richard G.; Higgins, Robert F.; Seefeld, ErinNota del Instructor HBS-808115-ETeaching Note for [806002].Desde 0,00 €
-
Jose Cuervo: Going Public
Jansat Mayench, Oriol; Carbonell López; Óscar; Rahnema Alavi, AhmadCaso F-975-EFinanzasThe initial public offering of José Cuervo (JC) in February 2017 marked a milestone in the world of tequila, as the first tequila company in the world to go public. The listing of the Mexican company was especially relevant because it took place months after the arrival of President Donald Trump to the White House. He had criticized the Mexican government and the need to renegotiate the North American Free Trade Agreement (NAFTA). The listing led...Desde 8,20 €
-
U.S. Food and Drug Administration
Higgins, Robert F.; Hamermesh, Richard G.; Fuller, Virginia A.Caso HBS-807050-ELiderazgo y Dirección de personasDescribes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure.Desde 8,20 €
-
Computerized Provider Order Entry at Emory Healthcare
Hamermesh, Richard G.; McFarlan, F. Warren; Morgan, Michael; Keil, Mark; Katz, Andrew; LaBorde, DavidCaso HBS-311061-ETecnologías de la informaciónThe Computerized Provider Order Entry at Emory Healthcare case presents one hospital system's efforts to implement computerized provider order entry (CPOE) across all of its hospitals and the challenges they faced in doing so. Issues such as standardizatiDesde 8,20 €